Colorectal Cancer
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About Colorectal Cancer

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Colorectal Cancer Local Doctors?
Elite in Colorectal Cancer
Elite in Colorectal Cancer

Duke Cancer Center

20 Duke Medicine Cir, 
Durham, NC 
Experience:
21+ years
Languages Spoken:
English
Offers Telehealth

I specialize in the treatment of gastrointestinal (GI) cancers with a focus on clinical trials. Clinical trial patients can come to me at any point during their disease, but they usually come to me looking for an alternative therapy once standard treatments have not been effective. I decided to become a doctor later in my career. I originally graduated from university with a non-science degree, but the excitement of advancing medical breakthroughs inspired me to start a career in medicine. As a Duke physician, I enjoy the diverse experiences that I get to have each week. In addition to taking care of patients and conducting research, I work closely with other doctors on crafting treatment plans. I also find it fulfilling to be able to apply my research to patient care. In my spare time, I enjoy spending time with my family, jogging and skiing. Dr. Strickler is rated as an Elite provider by MediFind in the treatment of Colorectal Cancer. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Pancreatic Cancer, Ampullary Cancer, and Familial Colorectal Cancer. Dr. Strickler is board certified in American Board Of Internal Med, Internal Medicine and American Board Of Internal Med, Medical Oncology.

Elite in Colorectal Cancer
Oncology
Elite in Colorectal Cancer
Oncology

Skip Viragh Outpatient Cancer Center

201 North Broadway Street, Viragh BLDG 5th FL, Viragh BLDG 5th FL, 
Baltimore, MD 
Languages Spoken:
English, Hindi, Urdu
Offers Telehealth

Dr. Nilofer S. Azad is Professor of Oncology at Johns Hopkins University School of Medicine and serves as the Associate Cancer Center Director for Clinical Research for the Johns Hopkins Sidney Kimmel Cancer Center. Dr. Azad earned her medical degree and completed a residency in internal medicine at Baylor College of Medicine in Houston, Texas. She then completed a fellowship in oncology and hematology at the National Institute of Health's National Cancer Institute in Bethesda, Maryland where she served as chief fellow. Dr. Azad’s research focused on early phase drug development and the intersection of moving exciting laboratory findings into patients for new treatment options Dr. Azad joined the faculty at the Kimmel Cancer Center in 2008. Dr. Azad’s clinical expertise is in cancers of the gastrointestinal tract, with a concentration in colorectal cancer, cholangiocarcinoma and pancreaticobiliary tract cancer. Her research efforts are dedicated to developing new drug combinations for patients with advanced cancer. In particular, Dr. Azad’s laboratory and clinical trials explore epigenetic therapy in combination with chemotherapy and immunotherapy to improve survival for patients, as well as molecularly targeted drugs. She is an active clinical trialist, leading multiple clinical trials of molecularly targeted agents for advanced cancer patients. Dr. Azad has received numerous grants for her work from entities such as the NCI (National Cancer Center), American Cancer Society, American Society of Clinical Research, Breakthrough Cancer Foundation, the Lustgarten Foundation, The Gateway Foundation, and the National Comprehensive Cancer Network, among others. She served as Principal for Johns Hopkins on the AACR Stand Up 2 Cancer Colorectal Cancer Dream Team and is a member of the Stand Up 2 Cancer Epigenetics Dream Team, leading the GI cancer initiatives for the group. Dr. Azad is a national leader in GI cancer, including serving as a member of the national NCI Colon Cancer Task Force and as Co-Chair of the Scientific and Medical Advisory Board for the Cholangiocarcinoma Foundation. She has a presidential appointment to the National Cancer Advisory Board. Dr. Azad is rated as an Elite provider by MediFind in the treatment of Colorectal Cancer. She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Cholangiocarcinoma (Bile Duct Cancer), Colorectal Cancer, Pancreatic Cancer, Hepato-Pancreato-Biliary Surgery, and Colonoscopy. Dr. Azad is board certified in American Board Of Internal Medicine.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Colorectal Cancer
Elite in Colorectal Cancer
675 N St Clair St Ste 21-100, Galter Pavilion, 
Chicago, IL 
Experience:
50+ years
Languages Spoken:
English
Offers Telehealth

Al Benson is an Oncologist practicing medicine in Chicago, Illinois. He has been practicing medicine for over 50 years. Dr. Benson is rated as an Elite provider by MediFind in the treatment of Colorectal Cancer. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Neuroendocrine Tumor, Carcinoid Syndrome, Liver Embolization, and Endoscopy. Dr. Benson is board certified in American Board Of Internal Medicine - Internal Medicine (Certified).

What are the latest Colorectal Cancer Clinical Trials?
Botensilimab + Balstilimab vs Best Supportive Care as Therapy in Chemo-refractory, Unresectable, Colorectal Adenocarcinoma: The BATTMAN Trial

Summary: This study is being done to answer the main question of: Do patients with colorectal cancer that cannot be removed by surgery, that is treated with two new immunotherapy drugs, botensilimab and balstilimab, live longer? Other important questions include: Is their quality of life better? Do their tumours slow in growth or possibly shrink in size? Are there markers in their tumour or blood that can ...

Match to trials
Find the right clinical trials for you in under a minute
Get started
The Effect of Mandala Art Therapy on Psychological Resilience and Coping With Cancer in Patients Undergoing Colorectal Cancer Surgery: a Prospective Randomized Controlled Study.

Summary: The aim of this study is to evaluate the effects of mandala art therapy on psychological resilience and coping with cancer in patients undergoing colorectal cancer surgery. This study was conducted as a randomized controlled trial with a pre-test-post-test design, including intervention and control groups. The study will be conducted between January 2026 and December 2026 with patients undergoing ...